01
The Economics of Buying and Billing Your Own Drugs
When your practice buys infusion drugs and administers them in-house, your profit is the gap between what you pay for the drug and what the insurer pays you back. That gap only survives if the billing is airtight. If the exact amount given to the patient isn't documented, if the portion left over and discarded from a single-use vial isn't accounted for, or if the location where care was delivered is recorded in a way that pays less, you end up reimbursed for less than the drug cost you - and an expensive infusion becomes a money-loser instead of a margin.
Your margin is the spread between drug acquisition cost and reimbursement - thin, and easy to erase
The full amount administered must be documented so you're paid for everything given
Leftover drug discarded from a single-use vial is separately reimbursable - capture it, don't absorb it
Where care is delivered changes what the drug pays - the setting has to be recorded correctly